AKARI THERAPTC Stock Price (NASDAQ:AKTX)

Add to My Stocks
$4.61 $0.03 (0.66%) AKTX stock closing price Jul 25, 2017 (Closing)
Prev Close* : $4.58
Market Cap:
$54.53M
Day Low: $4.52
52 Week Low: $4.11
Open: $4.71
Volume: 69405
Day High: $4.9
52 Week High: $22.20
Dividend:
N/A

Latest Stock Market News

Latest Articles

AKARI THERAPTC News - From Partners

AKTX Stockcharts

View AKTX PE ratio, PS ratio stocks charts and compare with peers.
AKTX Chart
Note: Compare AKARI THERAPTC stock price history with the index and industry peers.

AKTX Industry Peers

Company Price Change (%)
Psivida (PSDV)1.320.03 (2.22%)
Ovascience (OVAS)1.530.01 (0.66%)
Achillion Pharma (ACHN)4.220.05 (1.17%)
Alexion Pharma (ALXN)129.351.39 (1.06%)
Kura Oncology (KURA)9.40.1 (1.08%)
Flex Pharma (FLKS)4.330.43 (11.03%)
Chemocentryx (CCXI)10.090.16 (1.56%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Compugen (CGEN)4.050.65 (19.12%)
Idera Pharma (IDRA)2.060.14 (7.29%)
Merrimack Pharma (MACK)1.360.05 (3.82%)
PDL BioPharma (PDLI)2.460.08 (3.36%)
Horizon Pharma (HZNP)13.480.32 (2.43%)
Keryx Biopharma (KERX)7.450.16 (2.19%)
Acorda Therapeutics (ACOR)22.850.45 (2.01%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 25, 2017
CompanyPriceChange (%)
Novavax (NVAX)1.10.41 (27.15%)
Dynavax Technologies (DVAX)9.90.75 (7.04%)
Vital Therapies (VTL)2.650.15 (5.36%)
EXACT Sciences (EXAS)37.332.11 (5.35%)
China Biologic Products (CBPO)98.325.05 (4.89%)
Epizyme (EPZM)12.650.65 (4.89%)
Trevena (TRVN)2.820.14 (4.73%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 25, 2017

Akari Therapeutics PLC (ADR) Stock News - Partner Headlines

AKARI THERAPTC Financial Statements

income statement20162015201420132012
Net Sales Or Revenues-----
Net Income-18.14M-45.31M-9.64M-3.62M-4.26M
Total Operating Expense27.24M30.57M10.17M3.6M3.66M
view Akari Therapeutics PLC (ADR) income statement
balance sheet20162015201420132012
Total Assets45.87M69.89M6.48M7.83M1.12M
Total Liabilities11.77M21.17M1.62M2.01M4.48M
Shareholders Equity34.1M48.71M4.85M5.81M-3.36M
view Akari Therapeutics PLC (ADR) balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-1.45M4.67M0.26M-1.88M2.03M
Net Cash From (Used By) Operating Activities-24.62M-4.96M-9.46M-5.45M-2.13M
Increase (Decrease) In Prop Plant And Equipment-0.05M-0.01M-0.05M--
view Akari Therapeutics PLC (ADR) cashflow statement

AKARI THERAPTC Stock Message Board

As of last trading day, AKARI THERAPTC stock price was 4.58. The total market value as denoted by 54.53M for AKARI THERAPTC, is the market value of the company's outstanding shares. A value investor must look at the fundamentals of a stock, and perform AKARI THERAPTC valuation, even though in the short-term sentiment and current breaking news might affect AKARI THERAPTC stock price.

The terms stocks and shares mean the same thing. For Ex: AKARI THERAPTC stock price and AKARI THERAPTC share price mean the same thing. The volume of shares traded stood at 49936 on the last trading day, as is evident from AKARI THERAPTC stock chart, and AKTX stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. AKARI THERAPTC stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.